Free Sale Certificate (CFS) and the Consular Legalization Chain for Country-of-Origin Certificates

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The requirement on the EDE marketing authorization service page is explicit: the free sale or registration certificate must be issued by the competent authority of the country of origin and attested by the UAE embassy. The pitfall Chinese manufacturers fall into here is usually not the absence of a certificate but a broken link in the chain, or a certificate close to expiry. Our recommendation is to manage the attestation chain as a supply chain with its own timeline: confirm the eligibility of the issuing body, complete domestic notarization and consular legalization, submit the document to the UAE embassy for attestation, and re-check the validity period before shipment. A remediation at any link in this chain directly attacks the 45 working days review window.

  • The certificate must be issued by the competent authority of the country of origin and attested by the UAE embassy.
  • The typical failure modes are a broken chain rather than a missing certificate, and certificates that expire mid-review.
  • The chain should be managed like a time-sensitive supply chain, with each link sequenced and re-checked before shipment.
  • Any rework at one link consumes part of the 45 working days review window.
  • Formal validity and substantive content of the certificate must both pass; attestation does not cure content defects.

2. Legal basis

The legal basis combines the EDE service pages for marketing authorization and for classification with the conditions of Federal Decree-Law No. 38 of 2024. The table below reproduces the instruments cited in the source material and their key points.

EDE service page: Issuance of Marketing Authorization for a Medical DeviceIssuance of Marketing Authorization for a Medical Device (service page, no instrument number)Currently published on the EDE websiteRequired document: free sale or registration certificateIssued by the competent authority of the country of origin and attested by the UAE embassy
EDE service page: Classification of a Medical ProductClassification of a Medical Product (service page, no instrument number)Currently published on the EDE websiteRequired document: certificate of product statusProduct status certificates such as CPP, CFS, ISO or CE certificates issued by the competent authority of the country of origin are accepted; service timeline 10 working days
UAE Federal Decree-Law on the Regulation of Medical Products, Pharmacists and Pharmaceutical EstablishmentsFederal Decree-Law No. 38 of 2024Published in the Official Gazette on 2024-10-14; entered into force on 2025-01-02Article 6(1)(c) and (f)(c) assessment of the marketing authorization compliance and post-market outcomes in reference countries; (f) the GMP certificate must be issued by EDE, by the competent authority of the country of origin, or by a reference institution recognized by EDE

3. Expert insights

Insight 1: The essence of the attestation chain is step-by-step endorsement of the credibility of the issuing body. Embassy attestation resolves the question of whether a foreign official document is formally admissible within the UAE; it does not examine the content of the certificate. Our judgment is therefore that even with a complete attestation chain, a CFS that does not state the product name, the models, the manufacturer, and the free sale status may still trigger a deficiency request. Formal validity and substantive content are two lines that must both be passed.

Insight 2: The choice between the CFS and the CPP should serve the submission strategy. The classification service page accepts CPP, CFS, ISO and CE certificates alike, which shows that EDE is more flexible about document form at the classification stage; the marketing authorization stage, however, explicitly requires a free sale or registration certificate issued by the competent authority. Our recommendation is to use readily available documents at the classification stage to save time, but to prepare to the strictest standard for the marketing authorization stage, and never to infer the document standard of the submission stage from the acceptance outcome of the classification letter.

Insight 3: Validity management should be placed ahead of the submission schedule. There is no uniform statutory rule for the processing time of a CFS and its embassy attestation, or for the length of validity. Our practice is to review on a rolling basis every 12 months (practical estimate) and to reserve buffer time in the schedule for reissuance. A certificate expiring during the review period is harder to remedy than an error in the certificate content.

4. Practical recommendations

  • First confirm in the country of origin the competent authority authorized to issue the CFS, and avoid documents issued by industry associations or agents being blocked at the attestation stage.
  • Follow the chain in the order of notarization, consular legalization, and attestation by the UAE embassy; do not start the next link before the previous one is complete.
  • The certificate content must cover the complete list of models of the products to be registered; a missing model cannot be corrected with other documents during review.
  • Maintain a ledger of attested documents, review on a rolling basis every 12 months, and record the responsible person and the processing time (validity and processing time are practical estimates).
  • Use documents of different strength at the classification stage and the marketing authorization stage, and do not treat the acceptance of the classification letter as a signal of what will pass at the submission stage.
  • Keep two sets of the attested document, a colour scan and the paper original, using one for online submission and the other for on-site verification.

5. Verification checklist

  • □ The CFS has been issued by the competent authority of the country of origin, and the issuing body name matches the licence
  • □ The certificate states the product name, the models, the manufacturer name and address, and the free sale status
  • □ Notarization, consular legalization, and UAE embassy attestation have all been completed, with no missing link in the chain
  • □ The attested document is valid both on the acceptance date of the submission and throughout the expected review period
  • □ The model list corresponds item by item with the list of products to be registered, with no omissions and no additions
  • □ The product status certificate used at the classification stage does not contradict the CFS used at the submission stage

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the United Arab Emirates. Our team prepares MOHAP-compliant dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail